Open-Label Phase I-II Clinical Trial to Evaluate Treatment With Myocet/Taxotere/Herceptin as Primary Chemotherapy Treatment for HER2neu Positive Breast Cancer Patients.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Doxorubicin; Paclitaxel; Trastuzumab
- Indications Breast cancer
- Focus Adverse reactions; Therapeutic Use
- 26 Jul 2018 Biomarkers information updated
- 12 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Dec 2005 New trial record.